Clinical trial
Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
NCT00237328 · Duke University, Other · Completed
Key facts
| NCT number | NCT00237328 |
|---|---|
| Title | Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery |
| Official title | The Incidence of Thromboembolic Events in Patients With Antibodies to Heparin-PF4 After Cardiac Bypass |
| Acronym | HIT |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Thrombosis |
| Intervention type | Drug |
| Interventions | Heparin |
| Enrollment | 1,015 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2012 |
| First posted | Oct 12, 2005 |
| Last update posted | Feb 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: